Long-term outcomes of peroral endoscopic myotomy for achalasia: a systematic review and meta-analysis

Endoscopy. 2023 Feb;55(2):167-175. doi: 10.1055/a-1894-0147. Epub 2022 Jul 7.

Abstract

Background: The long-term outcomes of esophageal peroral endoscopic myotomy (POEM) are still unknown.

Methods: We searched electronic databases (MEDLINE/PubMed, EMBASE, Scopus) for studies assessing outcomes after POEM for esophageal achalasia with a minimum median follow-up duration of 36 months. Pooled rates of clinical success and postoperative reflux were calculated and compared with the same values at 12/24/36 months when available. Subgroup analyses were performed to explore the interstudy heterogeneity.

Results: From 1528 initial records, 11 studies (2017-2021) were included. A total of 2342 patients (age 48.1 [SD 6.8] years; 50.1 % males) with a median follow-up of 48 months (interquartile range 45-60) were analyzed. The pooled clinical success rate was 87.3 % (95 %CI 83.6 %-91.0 %; I2 = 73.1 %). The symptomatic reflux pooled rate was 22.0 % (95 %CI 14.4 %-29.5 %; I2 = 92.7 %). Three cases of peptic strictures and one Barrett's esophagus were reported. The pooled rate of severe adverse events was 1.5 % (95 %CI 0.5 %-2.5 %; I2 = 52.8 %).

Conclusions: Long-term clinical efficacy of POEM persisted in 87 % of patients with achalasia. Post-POEM symptomatic reflux remained stable over time. The risk for Barrett's esophagus and peptic strictures appeared minimal.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Barrett Esophagus*
  • Constriction, Pathologic
  • Esophageal Achalasia* / surgery
  • Esophageal Sphincter, Lower / surgery
  • Female
  • Gastroesophageal Reflux*
  • Heller Myotomy* / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Natural Orifice Endoscopic Surgery* / adverse effects
  • Treatment Outcome